TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Piramal Pharma Ltd.

PPLPHARMA on NSE · 19 Nov 2026

NIFTY 500

239.65 ▲ +0.29 % on the day

Overview Technical Risk & rank Results Accounts Filings Options Guidance & governance

Balance sheet

What the company owns and owes, as reported.

₹ cr30 Sep 202631 Mar 202630 Sep 202530 Sep 202431 Mar 202430 Sep 2023
Total assets18,53717,96516,18915,24215,31214,776
Equity attributable to owners8,1428,1638,0747,9077,9117,758
Current borrowings1,2121,1961,3993,1082,0751,543
Non-current borrowings4,4544,3003,3171,5352,4842,861
Cash and cash equivalents5451,200499270357252

Cash flow

Where the cash came from and went, by financial year.

₹ crYear to Mar 2026Year to Mar 2024Year to Mar 2023
Cash flow from operating activities1,6531,005484
Cash flow from investing activities-826-434-1,339
Cash flow from financing activities-39-422818
Purchase of property, plant and equipment890712965

Figures are consolidated, in ₹ cr unless the line is a percentage, from the company's results filed with NSE. Companies report a balance sheet twice a year and cash flow for the year to date; a dash means the line was not reported.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in